Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2016

Drugs and Therapeutics (D & T) Committee

Drugs Under Review for:

September 14, 2016

Drug Name	Review Type	Class	Manufacturer
Viekira HR	New Drug Initial Review	Hepatitis C	AbbVie
Ocaliva	New Drug Initial Review	Primary Biliary Cholangitis	Intercept Pharmaceuticals
Briviact	New Drug Initial Review	Anticonvulsant	UCB, Inc.
Epclusa	New Drug Initial Review	Hepatitis C	Gilead Sciences
Xtampza ER	New Drug Initial Review	Extended Release Opioid	Collegium Pharmaceutical
Spinosad	New Drug Initial Review	Lice Treatment	ParaPro
Adzenys XR-ODT	New Drug Initial Review	Stimulant	Neos Therapeutics
Orenitram	New Drug Appeal	Pulmonary Arterial Hypertension	United Therapeutics